Dr. Lenore Ocava is Director of the Stroke Center at Jacobi Medical Center and Associate Director of the Neurology Residency Training Program at AECOM. Her research interests include cerebral ischemia and stroke intervention (acute care and secondary prevention).
1. Dhallu, MS, Savitz, SI, Malhotra, S, Mammis, A, Ocava, LC, Rosenbaum, PS, Rosenbaum DM. EDG receptors as pontential therapeutic target in the retinal ischemic reperfusion injury. In print, Brain Research. 2.Min, L., Zwerling, J., Ocava, L.C., Chen I.A., Putterman, C. Reversible Posterior Leukoencephalopathy in Connectiuve Tissue Diseases. Semin Arthritis Rheum 2006 June: 35:388-395. 3. Ocava, L.C., Singh, M., Malhotra, S., Rosenbaum, D.M. Antithrombotic and thrombolytic therapy for ischemic stroke. Clin Geriatr Med. 2006 Feb;22(1):135-54 4. Malhotra, S., Ocava, L.C., Savitz, S.I., Rosenbaum, D.M., Erythropoietin (EPO) is neuroprotective and may play a role in ischemic preconditioning. J Neurosci Res. 2006 Jan 1;83(1):19-27 5. Bendixen,BH and Ocava,LC. Evaluation and Management of Acute Ischemic Stroke. Curr Cardiol Rep 2002 Mar:4(2):149-57
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.